1 Min Read
Oct 23 (Reuters) - Roka Bioscience Inc
* Edward Painter, CEO of A2A Pharmaceuticals, dissolves share stake in Roka Bioscience Inc as of Oct 20 - SEC filing Source text: (bit.ly/2ladEo7) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.